Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Cutter

Showing results (11-20 of 333) with videos related to

Pageof 34
Sort By:
Annals of Neurology|April 21, 2007
Interferon-beta for multiple sclerosis: Long-term benefits?Richard A Rudick, Gary Cutter
Neurology. Clinical Practice|January 30, 2018
Long-term registries: Answering tough questions with big data?Robert J Fox, Gary Cutter
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2025
Lost in dichotomization: Preserving statistical power and sensitivity in MS cognitive researchJeroen Van Schependom, Gary Cutter
Multiple Sclerosis and Related Disorders|September 21, 2025
The ever growing incidence of Meta-Analyses and ReviewsFernanda L Schumacher, Gary Cutter
The Lancet. Neurology|June 8, 2013
MRI lesions: a surrogate for relapses in multiple sclerosis?Richard A Rudick, Gary Cutter
Neurology|November 6, 2009
Relapses in multiple sclerosis: important or not?Ruth Ann Marrie, Gary Cutter
Contemporary Clinical Trials|January 5, 2011
Bayesian sample size determination under hypothesis testsXiao Zhang, Gary Cutter, Thomas Belin
The New England Journal of Medicine|October 28, 2020
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney InjuryJosée Bouchard, Gary Cutter, Ravindra Mehta
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 17, 2011
Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosisRuth Ann Marrie, Gary Cutter, Tuula Tyry
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Clinical trial design for progressive MS trialsMatteo Pardini, Gary Cutter, Maria Pia Sormani
Pageof 34

Showing results (11-20 of 333) with videos related to

Sort By:
Pageof 34
Annals of Neurology|April 21, 2007
Interferon-beta for multiple sclerosis: Long-term benefits?Richard A Rudick, Gary Cutter
Neurology. Clinical Practice|January 30, 2018
Long-term registries: Answering tough questions with big data?Robert J Fox, Gary Cutter
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2025
Lost in dichotomization: Preserving statistical power and sensitivity in MS cognitive researchJeroen Van Schependom, Gary Cutter
Multiple Sclerosis and Related Disorders|September 21, 2025
The ever growing incidence of Meta-Analyses and ReviewsFernanda L Schumacher, Gary Cutter
The Lancet. Neurology|June 8, 2013
MRI lesions: a surrogate for relapses in multiple sclerosis?Richard A Rudick, Gary Cutter
Neurology|November 6, 2009
Relapses in multiple sclerosis: important or not?Ruth Ann Marrie, Gary Cutter
Contemporary Clinical Trials|January 5, 2011
Bayesian sample size determination under hypothesis testsXiao Zhang, Gary Cutter, Thomas Belin
The New England Journal of Medicine|October 28, 2020
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney InjuryJosée Bouchard, Gary Cutter, Ravindra Mehta
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 17, 2011
Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosisRuth Ann Marrie, Gary Cutter, Tuula Tyry
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Clinical trial design for progressive MS trialsMatteo Pardini, Gary Cutter, Maria Pia Sormani
Pageof 34